FDA: Former Metformin maker is recalling their product due to carcinogen concerns

  • By cvbizz
  • May 29, 2020
  • 0
  • 62 Views

via foxcarolina.com

Share This Post!

WASHINGTON (FOX Carolina) – The FDA said Apotex Corp is voluntarily recalling all lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg at retail level after the agency said tests of one lot of the drug found N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

The FDA said

Read Full Post


Upstate News Headlines

PHP Code Snippets Powered By : XYZScripts.com